Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15961576rdf:typepubmed:Citationlld:pubmed
pubmed-article:15961576lifeskim:mentionsumls-concept:C0021051lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15961576lifeskim:mentionsumls-concept:C2826170lld:lifeskim
pubmed-article:15961576pubmed:issue3lld:pubmed
pubmed-article:15961576pubmed:dateCreated2005-8-29lld:pubmed
pubmed-article:15961576pubmed:abstractTextOur previous investigation of a patient (pt1) with non-X-linked hyper-immunoglobulin M syndrome revealed a CD40-mediated defect in B cell activation that resulted in low CD23 expression and absence of germ-line transcription and class-switch recombination. These deficiencies were complemented in vitro by a high threshold of sustained signaling through CD40. To further analyze the signaling defect in pt1 B cells, two types of Epstein-Barr virus lymphoblastoid cell lines (LCLs) were generated that either constitutively expressed the viral transforming protein latent membrane protein-1 (LMP1; pt1-LCL) or expressed it under the control of a tet-inducible promoter (pt1-LCL(tet)). Because LMP1 signals through the CD40 pathway, the pt1-LCL and pt1-LCL(tet) lines allow comparison of downstream functions in response to either constitutive LMP1 signals or regulated LMP1 and CD40 signals. Immortalized pt1-LCLs were initially CD23(lo)/CD38(hi) and reverted to a CD23(hi)/CD38(lo) phenotype upon extended growth in culture, suggesting that the CD40 defect was reversed by selection and/or constitutive expression of LMP1. In contrast, pt1-LCL(tet) cells retained the CD23(lo)/CD38(hi) phenotype after extended periods of culture and failed to up-regulate CD23 in response to CD40 signals. Analysis of pt1-LCL(tet) cells in response to the CD40 signals in the presence or absence of LMP1 revealed that mitogenic activation resulted only from LMP1 and not CD40, indicating a difference in the response of pt1 B cells to these two distinct signals. Together, these data demonstrate that the pt1-LCL(tet) cells maintain the CD40-related defect and provide a unique approach to study the independent effects of LMP1- and CD40-directed signals.lld:pubmed
pubmed-article:15961576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:languageenglld:pubmed
pubmed-article:15961576pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:citationSubsetIMlld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15961576pubmed:statusMEDLINElld:pubmed
pubmed-article:15961576pubmed:monthSeplld:pubmed
pubmed-article:15961576pubmed:issn0741-5400lld:pubmed
pubmed-article:15961576pubmed:authorpubmed-author:LuKristina...lld:pubmed
pubmed-article:15961576pubmed:authorpubmed-author:CoveyLori RLRlld:pubmed
pubmed-article:15961576pubmed:authorpubmed-author:DryerRebecca...lld:pubmed
pubmed-article:15961576pubmed:authorpubmed-author:SongCharlesClld:pubmed
pubmed-article:15961576pubmed:issnTypePrintlld:pubmed
pubmed-article:15961576pubmed:volume78lld:pubmed
pubmed-article:15961576pubmed:ownerNLMlld:pubmed
pubmed-article:15961576pubmed:authorsCompleteYlld:pubmed
pubmed-article:15961576pubmed:pagination620-9lld:pubmed
pubmed-article:15961576pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:meshHeadingpubmed-meshheading:15961576...lld:pubmed
pubmed-article:15961576pubmed:year2005lld:pubmed
pubmed-article:15961576pubmed:articleTitleMaintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV.lld:pubmed
pubmed-article:15961576pubmed:affiliationNelson Biological Laboratories, Rutgers, The State University of New Jersey, 604 Allison Road, Piscataway, NJ 08854, USA.lld:pubmed
pubmed-article:15961576pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15961576pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15961576pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15961576pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15961576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15961576lld:pubmed